Detection of telomerase activity in hepatocellular carcinoma by fluorescence-based TRAP method

International Hepatology Communications

Volumn 6, Issue 1, 1996, Pages 29-35

  Hisatomi, Hisashi ^a   Kawaoto, Yasuko ^a   Ohmura, Yoshimi ^a   Kuwahara, Miwako ^a   Yamauchi, Toshiyasu ^a   Hikiji, Kazumasa ^a  

^a SRL INC   (Japan)

Author keywords

hepatocellular carcinoma; telomerase; TRAP

Indexed keywords

ENZYME; TELOMERASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; PRIORITY JOURNAL; TELOMERE;

EID: 0030297698     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4346(96)00323-4     Document Type: Article

References (17)

1. [1] Wright WE, Pereiro-Smith OM, Shay JW. Reversible cellular senescence, implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol 1989; 9: 3088-3092.
2. [2] Shay JW, Pereira-Smith OM, Wright WE. A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 1991; 196: 33-39.
3. [3] Moyzis RK, Buckingham JM, Crom SH, et al. A highly conserved repetitive DNA sequence, (TTAGGG)n. present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988; 85: 6622-6626.
4. [4] Harley CB. Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345: 458-460.
5. [5] Hastie ND, Dempster M, Dunlop MG. et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990; 346: 866-868.
6. [6] Murakami Y. Hayashi K. Hirohashi S. et al. Aberrations of the tumor suppressor p53 and retinoblasto, a genes in human hepatocellular carcinomas. Cancer Res 1991; 51: 5520-5525.
7. [7] Ueda H. Ullrich SJ, Gangemi JD, et al. Functional inactivation but not structural mutation of p53 causes liver cancer. Nature Genet 1995; 9: 41-47.
8. [8] Emi M, Fujiwara Y, Nakajima T, et al. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res 1992; 52: 5368-5372.
9. [9] Zhang W, Hirohashi S. Tsuda H, et al. Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res 1990; 81: 108-111.
10. [10] Buetow KH, Murray JC, Israel JL, et al. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA 1989; 86: 8852-8856.
11. [11] Aden DP, Fogel A, Plotkin S. et al. Controlled synthesis of HBsAg in a defferentioated human liver carcinoma derived cell line. Nature 1979; 282: 615-616.
12. [12] Kim NW, Piatyszek MA, Prowse KR. et al. Specific association of human telomerose activity with immortal cells and cancer. Science 1994; 266: 2011-2015.
13. [13] Hiyama K, Hiyama E, Ishioka S. et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995; 87: 895-902.
14. [14] Longford LA, Piatyszek MA, Xu R, et al. Telomerase activity in human brain tumors. The Lancet 1995; 346: 1267-1268.
15. [15] Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerose activity in gastric cancer. Cancer Res 1995; 55: 3258-3262.
16. [16] Chadeneau C. Hay K. Hirte HW, et al. Telomerose activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995; 55: 2533-2536.
17. [17] Tahara H. Nakanishi T, Kitamoto M, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995; 55: 2734-2736.